Skip to content

EBITDA margin at other companies

Merck & Co. logo
Merck & Co.MRK
22.4%-12.4pp
Zoetis logo
ZoetisZTS
42.3%+0.6pp
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
14.9%
Neogen logo
NeogenNEOG
-59.6%+135pp
Balchem logo
BalchemBCPC
24.7%+0.1pp
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-135.4%-153pp

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.27B+31.4%
Enterprise value$1.25B+33.9%
P/E13.4×-17.1×
P/S0.9×0.0×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Calculated from Phibro Animal Health’s reported figures.

Based on trailing twelve months.

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phibro Animal Health's EBITDA margin?
Phibro Animal Health (PAHC) reported EBITDA margin of 15.4% in Q1 2026.
How has Phibro Animal Health's EBITDA margin changed year-over-year?
Phibro Animal Health's EBITDA margin increased by 33.0% year-over-year, from 11.6% to 15.4%.
What is the long-term trend for Phibro Animal Health's EBITDA margin?
Over 4 years (2021 to 2025), Phibro Animal Health's EBITDA margin has grown at a -1.5% compound annual growth rate (CAGR), from 12.8% to 12%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.